FDA-SEC information sharing heightens focus on life science company disclosures
[co-author: Steve Nicolai] The U.S. Securities and Exchange Commission (SEC) and the U.S. Food and Drug Administration (FDA) have signed a Memorandum of Understanding (MOU) establishing a cooperative framework for interagency information sharing, including …